Indian Journal of Sexually Transmitted Diseases and AIDS

Scope & Guideline

Empowering public health through innovative research.

Introduction

Welcome to the Indian Journal of Sexually Transmitted Diseases and AIDS information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Indian Journal of Sexually Transmitted Diseases and AIDS, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2589-0557
PublisherWOLTERS KLUWER MEDKNOW PUBLICATIONS
Support Open AccessNo
CountryIndia
TypeJournal
Convergefrom 2018 to 2024
AbbreviationINDIAN J SEX TRANSM / Indian J. Sex Transm. Dis. AIDS
Frequency2 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressWOLTERS KLUWER INDIA PVT LTD, A-202, 2ND FLR, QUBE, C T S NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra 400059, INDIA

Aims and Scopes

The Indian Journal of Sexually Transmitted Diseases and AIDS focuses on the comprehensive study and management of sexually transmitted infections (STIs) and HIV/AIDS, emphasizing clinical, epidemiological, and therapeutic aspects. The journal aims to bridge the gap between clinical practice and research, providing a platform for professionals to share findings and advancements in the field.
  1. Clinical Research on STIs and HIV/AIDS:
    The journal publishes original research articles that explore clinical presentations, treatment outcomes, and management strategies for sexually transmitted infections and HIV/AIDS.
  2. Epidemiological Studies:
    It features studies that investigate the prevalence, risk factors, and trends of sexually transmitted diseases, contributing to public health awareness and intervention strategies.
  3. Case Reports and Unique Presentations:
    The journal highlights rare and unusual cases of STIs and HIV-related conditions, providing insights into atypical presentations and complications.
  4. Therapeutic Advances and Drug Resistance:
    Research focusing on the efficacy of treatments, adherence to antiretroviral therapy, and emerging drug resistance patterns in HIV and STIs is a core area of interest.
  5. Public Health and Policy:
    The journal addresses public health implications of STIs and HIV/AIDS, discussing policy changes, health education, and strategies for prevention and control.
  6. Dermatological Manifestations:
    A significant focus is placed on the dermatological aspects of STIs, including skin manifestations associated with infections like syphilis and herpes.
The journal is evolving with the changing landscape of sexually transmitted infections and HIV/AIDS research. Recent publications highlight emerging themes that reflect current public health challenges and advancements in medical science.
  1. Syphilis Resurgence and Epidemiology:
    There is an increasing focus on the resurgence of syphilis, including its epidemiology, clinical presentations, and public health implications, reflecting a global trend in STI rates.
  2. Impact of COVID-19 on STI Management:
    Research exploring how the COVID-19 pandemic has affected the management of STIs and HIV is on the rise, addressing disruptions in services and changes in patient behavior.
  3. Molecular Diagnostics and Testing:
    Emerging themes include the use of advanced molecular techniques for diagnosing STIs, indicating a shift towards more precise and rapid testing methods.
  4. Drug Resistance in STIs and HIV:
    There is a growing emphasis on the study of drug resistance patterns in STIs and HIV, highlighting the need for ongoing surveillance and adaptation of treatment protocols.
  5. Public Health Interventions and Education:
    Recent publications indicate a trend towards evaluating the effectiveness of public health interventions, educational programs, and community outreach in reducing STI prevalence.
  6. Sexual Health in Special Populations:
    Increased attention is being paid to the sexual health of specific populations, such as adolescents, pregnant women, and the elderly, reflecting a broader understanding of diverse health needs.

Declining or Waning

While the journal has consistently focused on key areas of sexually transmitted diseases and HIV/AIDS, certain themes are becoming less prominent in recent publications. These declining scopes may reflect shifts in research priorities or emerging interests in other areas.
  1. Non-venereal Dermatoses:
    There appears to be a decrease in studies specifically focusing on non-venereal dermatoses related to STIs, possibly as the field shifts back towards more traditional venereal diseases.
  2. Opportunistic Infections in HIV:
    Research on opportunistic infections, while still relevant, seems to be less frequent, indicating a possible shift in focus towards more preventive strategies and the management of HIV itself.
  3. Longitudinal Studies on HIV Progression:
    There has been a noticeable decline in longitudinal studies tracking HIV infection progression, which may suggest a transition towards cross-sectional or retrospective studies instead.
  4. Psychosocial Aspects of STIs:
    While some psychosocial research remains, there is a reduction in articles explicitly addressing psychological health and well-being in STI patients, which may indicate a narrowing of focus on clinical rather than psychosocial aspects.

Similar Journals

INTERNATIONAL JOURNAL OF STD & AIDS

Bridging gaps in understanding and treatment.
Publisher: SAGE PUBLICATIONS LTDISSN: 0956-4624Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF STD & AIDS is a prominent publication dedicated to advancing the understanding and treatment of sexually transmitted diseases and HIV/AIDS. Published by SAGE Publications Ltd, this esteemed journal has been contributing to the medical community since 1990, with a convergence of studies spanning to 2024. With its ISSN 0956-4624 and E-ISSN 1758-1052, the journal is recognized for its rigorous peer-reviewed research and has successfully positioned itself in the second quartile (Q2) of Dermatology and Public Health, alongside notable rankings in Infectious Diseases and Pharmacology. Currently based in the United Kingdom, this journal serves as a crucial resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and critical reviews that address global health challenges. Although it does not offer Open Access, the journal continues to maintain its reputation as a vital reference point for those invested in the fields of dermatology, public health, and infectious diseases.

Therapeutic Advances in Infectious Disease

Advancing the frontiers of infectious disease treatment.
Publisher: SAGE PUBLICATIONS LTDISSN: 2049-9361Frequency: 6 issues/year

Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.

AIDS Research and Treatment

Advancing knowledge, transforming lives.
Publisher: HINDAWI LTDISSN: 2090-1240Frequency: 1 issue/year

AIDS Research and Treatment is a premier open access journal published by HINDAWI LTD, dedicated to advancing the understanding and treatment of HIV/AIDS and related conditions. Launched in 2010, the journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of Dermatology, Immunology, Infectious Diseases, and Public Health. With a notable 2023 impact factor reflected in its Q2 and Q3 quartile rankings across key medical categories, the journal plays a critical role in disseminating high-quality research and fostering innovation in the prevention and treatment of AIDS. It provides a wide range of open access options, enabling easier dissemination and increased visibility of research findings globally. As the landscape of HIV/AIDS research continues to evolve, AIDS Research and Treatment remains at the forefront, ensuring crucial insights and developments are shared to enhance public health outcomes.

Reumatismo

Elevating understanding of rheumatic conditions through open access.
Publisher: PAGEPRESS PUBLISSN: 0048-7449Frequency: 4 issues/year

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

International Journal of Mycobacteriology

Innovating solutions for mycobacterial infections worldwide.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2212-5531Frequency: 4 issues/year

International Journal of Mycobacteriology is a peer-reviewed, open-access journal published by Wolters Kluwer Medknow Publications that specializes in the field of infectious diseases with a particular emphasis on mycobacterial research. Since its inception in 2012, this journal has emerged as a vital resource for researchers, healthcare professionals, and students aimed at advancing understanding and treatment of mycobacterial infections, including tuberculosis. With the journal being indexed in Scopus and holding a Q3 ranking in both Infectious Diseases and Microbiology (medical) for 2023, it reflects a substantial contribution to scholarly discourse in these domains, despite its current ranking positioning. Authors and readers benefit from the open access model, ensuring widespread dissemination of research findings and fostering collaboration across the global health community. Located in Mumbai, India, the journal continues to thrive with a commitment to quality research and innovation, welcoming contributions that further the exploration of mycobacteriology throughout the converged years from 2012 to 2024.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Advancing knowledge in HIV/AIDS research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1525-4135Frequency: 15 issues/year

JAIDS - Journal of Acquired Immune Deficiency Syndromes, is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the dynamics of HIV/AIDS and its broader implications in the fields of infectious diseases and pharmacology. With an esteemed impact factor that places it in the prestigious Q1 category for both Infectious Diseases and Pharmacology (medical) as of 2023, this journal aims to provide a platform for groundbreaking research, clinical findings, and innovative therapies relevant to the management and prevention of HIV/AIDS. The journal's rigorous editorial standards and commitment to advancing knowledge make it an essential resource for researchers, healthcare professionals, and students invested in the global response to AIDS. Although the journal does not currently offer open access options, it remains instrumental in disseminating high-quality research that shapes clinical practices and policy developments in the field.

INDIAN JOURNAL OF DERMATOLOGY

Exploring innovations in dermatology for a healthier tomorrow.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0019-5154Frequency: 6 issues/year

INDIAN JOURNAL OF DERMATOLOGY, published by Wolters Kluwer Medknow Publications, is a renowned open-access journal that has been a significant platform for disseminating vital research in the field of dermatology since its inception in 1962. With an ISSN of 0019-5154 and an E-ISSN of 1998-3611, the journal covers a comprehensive array of topics relevant to skin health and diseases, serving both academic and clinical audiences in India and beyond. Having transitioned to an open access model in 2005, it strives to enhance the reach and impact of dermatological research. The journal is classified in the Q3 quartile within the dermatology category as of 2023 and ranks 82 out of 142 in Scopus, showcasing its contribution to the field despite competitive rankings. By fostering scholarly communication and providing a rigorous peer-review process, the INDIAN JOURNAL OF DERMATOLOGY remains a vital resource for researchers, practitioners, and students devoted to advancing the understanding and treatment of skin disorders.

Dermatologica Sinica

Transforming Skin Care with Cutting-edge Research
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1027-8117Frequency: 4 issues/year

Dermatologica Sinica, published by Wolters Kluwer Medknow Publications, is an esteemed open-access journal in the field of dermatology that has been disseminating critical research since its inception in 2005. With an E-ISSN of 2223-330X and an ISSN of 1027-8117, this journal presents a platform for researchers, clinicians, and students to share cutting-edge findings and advancements in dermatological science. As of 2023, it proudly ranks in the Q2 category of dermatology journals and holds a notable position at rank #62 out of 142 in the Scopus Medicine - Dermatology category, placing it in the 56th percentile for impact. The journal transitioned to an open-access model in 2016, enhancing accessibility and visibility for groundbreaking studies worldwide. With a commitment to fostering innovation in the dermatological community, Dermatologica Sinica aims to advance the understanding and treatment of skin diseases while encouraging scholarly dialogue among practitioners and researchers across the globe.

Frontiers in Reproductive Health

Innovating Reproductive Health Research.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Reproductive Health is a leading open-access journal published by Frontiers Media SA in Switzerland, dedicated to advancing the field of reproductive health through high-quality research and comprehensive reviews. With a commitment to fostering an interdisciplinary dialogue, this journal covers an array of topics including epidemiology, family practice, obstetrics and gynecology, and reproductive medicine. As of 2023, it ranks in the Q3 quartile in Epidemiology, Q1 in Family Practice, and Q2 in both Obstetrics and Gynecology and Reproductive Medicine, reflecting its significance and growing influence in these areas. Researchers and professionals can benefit from the journal's wide distribution and open access policy, which facilitates the sharing of knowledge and enhances the visibility of their work. By embracing innovative studies and harnessing the talents of both established scholars and emerging voices, Frontiers in Reproductive Health plays a crucial role in shaping the future of reproductive health research and practice.

Journal of Pediatric Infectious Diseases

Connecting research and practice in pediatric infectious diseases.
Publisher: GEORG THIEME VERLAG KGISSN: 1305-7707Frequency: 4 issues/year

Journal of Pediatric Infectious Diseases, published by GEORG THIEME VERLAG KG, serves as a vital platform for the dissemination of cutting-edge research in the fields of pediatric infectious diseases and related areas. With an ISSN of 1305-7707 and an E-ISSN of 1305-7693, this journal endeavors to address critical issues and innovations in pediatric medicine, fostering an understanding of infectious diseases that affect children. The journal is indexed in Scopus, where it holds a Q4 ranking in both Infectious Diseases and Pediatrics, Perinatology and Child Health, reflecting its emerging status within medical research. Although currently not open access, it offers valuable insights and empirical research crucial for healthcare professionals, researchers, and students dedicated to improving pediatric care. The Journal of Pediatric Infectious Diseases not only highlights contemporary challenges faced by pediatric health practitioners but also aims to be a cornerstone for future developments in the management and prevention of infections in young populations.